COVID-19 in Patients With Chronic Liver Diseases
Purpose
This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Conditions
- COVID-19
- Chronic Liver Disease
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Confirmed diagnosis of COVID-19 - Personal history of either - Chronic hepatitis C - Chronic hepatitis B - Alcoholic liver disease - Non alcoholic liver disease - Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis - Cryptogenic cirrhosis - Hepatocellular carcinoma
Exclusion Criteria
- Non-COVID-19 patient
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Chronic Liver Disease Group | COVID-19 patients with Chronic Liver Disease. |
|
Control Group | COVID-19 patients without Chronic Liver Disease. |
|
Recruiting Locations
More Details
- NCT ID
- NCT04439084
- Status
- Completed
- Sponsor
- Stanford University